VANGUARD GROUP INC
Institutional investor · Portfolio as of Q3 2024
Top Holdings4,351 positions
Stock | Shares | Value | Weight | Avg Buy | Est. P&L | Held | Conviction |
|---|---|---|---|---|---|---|---|
APPLE INC | 1.3B | $313.8B | 5.6% | $226.30 | 0.00% | 1 qtr | New 98 |
MICROSOFT CORP | 673.6M | $289.9B | 5.2% | $424.04 | 0.00% | 1 qtr | New 98 |
NVIDIA CORP | 2.1B | $260.3B | 4.7% | $121.36 | 0.00% | 1 qtr | New 88 |
AMAZON.COM INC | 805.7M | $150.1B | 2.7% | $187.97 | 0.00% | 1 qtr | New 83 |
META PLATFORMS INC-CLASS A | 189.7M | $108.6B | 1.9% | $565.12 | 0.00% | 1 qtr | New 73 |
ALPHABET INC-CL A | 499.6M | $82.9B | 1.5% | $163.12 | 0.00% | 1 qtr | New 73 |
BROADCOM INC | 468.6M | $80.8B | 1.4% | $170.69 | 0.00% | 1 qtr | New 73 |
ALPHABET INC-CL C | 407.8M | $68.2B | 1.2% | $164.46 | 0.00% | 1 qtr | New 73 |
BERKSHIRE HATHAWAY INC-CL B | 146.4M | $67.4B | 1.2% | $457.47 | 0.00% | 1 qtr | New 73 |
ELI LILLY & CO | 73.8M | $65.4B | 1.2% | $868.40 | 0.00% | 1 qtr | New 73 |
TESLA INC | 239.6M | $62.7B | 1.1% | $260.46 | 0.00% | 1 qtr | New 73 |
JPMORGAN CHASE & CO | 272.2M | $57.4B | 1.0% | $203.96 | 0.00% | 1 qtr | New 73 |
EXXON MOBIL CORP | 432.1M | $50.7B | 0.9% | $110.08 | 0.00% | 1 qtr | New 62 |
UNITEDHEALTH GROUP INC | 85M | $49.7B | 0.9% | $565.70 | 0.00% | 1 qtr | New 62 |
VISA INC-CLASS A SHARES | 152.3M | $41.9B | 0.7% | $272.15 | 0.00% | 1 qtr | New 62 |
PROCTER & GAMBLE CO/THE | 228.2M | $39.5B | 0.7% | $166.91 | 0.00% | 1 qtr | New 62 |
HOME DEPOT INC | 94.9M | $38.4B | 0.7% | $387.77 | 0.00% | 1 qtr | New 62 |
MASTERCARD INC - A | 76.8M | $37.9B | 0.7% | $489.43 | 0.00% | 1 qtr | New 62 |
JOHNSON & JOHNSON | 231M | $37.4B | 0.7% | $155.36 | 0.00% | 1 qtr | New 62 |
COSTCO WHOLESALE CORP | 41.7M | $37B | 0.7% | $878.65 | 0.00% | 1 qtr | New 62 |
VANGUARD GROUP INC manages $5.6T across 4351 positions as of Q3 2024. Top holdings: AAPL (5.6%), MSFT (5.2%), NVDA (4.7%). Fund DNA: Balanced Allocator.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR